Michele Maio

15PUBLICATIONS
135CO-AUTHORS
Tumour immunologyMedical mycologyMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 07, 2026
Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy.

|May 07, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

|Nov 24, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.

Erika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo

|Jul 03, 2025
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047.

Evan J Lipson, Sonia Dolfi, Hao Tang

|Mar 06, 2025
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301).

Adi Diab, Paolo A Ascierto, Michele Maio

|Sep 22, 2023
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.

Teresa Maria Rosaria Noviello, Anna Maria Di Giacomo, Francesca Pia Caruso

Pageof 3

Frequent Collaborators

4 joint publications

Paolo A Ascierto

4 joint publications

Andrea Anichini

4 joint publications

Francesca Pia Caruso

4 joint publications

Anna Maria Di Giacomo